Biologic drugs, mental health and diabetes, all significant cost drivers, were each examined at a recent webinar.
Overprescribing costs $2 billion a year.
Insurers should be less affected by inflation than other economic sectors, one reinsurer predicts.
Specialty drugs are driving cost trends significantly, while the number of Canadians making claims under their group hea
Canadians have trouble paying for drugs, showing need for universal pharmacare, say groups.
Health Canada says the Canadian government remains committed to a national, universal pharmacare program including a rar
TELUS Health, Canada Life and Innomar Strategies are spearheading an electronic prior authorization solution for medicat